Our study extends this paradigm by demonstrating that breast cancer-derived exosomal miR-221-3p remotely disrupts the brain vascular niche via LIFR-mediated glycolytic activation and tight junction impairment. The gene discussed is LIFR; the disease is breast carcinoma.